Charles River Laboratories International Inc (CRL)
229.02
+1.21
(+0.53%)
USD |
NYSE |
Apr 26, 16:00
229.02
0.00 (0.00%)
After-Hours: 19:20
Charles River Laboratories International Enterprise Value: 14.13B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 14.13B |
| April 24, 2024 | 14.73B |
| April 23, 2024 | 14.76B |
| April 22, 2024 | 14.37B |
| April 19, 2024 | 14.08B |
| April 18, 2024 | 14.12B |
| April 17, 2024 | 14.25B |
| April 16, 2024 | 14.36B |
| April 15, 2024 | 14.55B |
| April 12, 2024 | 14.83B |
| April 11, 2024 | 15.09B |
| April 10, 2024 | 15.14B |
| April 09, 2024 | 15.64B |
| April 08, 2024 | 15.52B |
| April 05, 2024 | 15.43B |
| April 04, 2024 | 15.30B |
| April 03, 2024 | 15.75B |
| April 02, 2024 | 15.88B |
| April 01, 2024 | 16.23B |
| March 28, 2024 | 16.35B |
| March 27, 2024 | 16.26B |
| March 26, 2024 | 16.06B |
| March 25, 2024 | 16.07B |
| March 22, 2024 | 16.43B |
| March 21, 2024 | 16.47B |
| Date | Value |
|---|---|
| March 20, 2024 | 16.20B |
| March 19, 2024 | 16.12B |
| March 18, 2024 | 15.89B |
| March 15, 2024 | 15.73B |
| March 14, 2024 | 15.81B |
| March 13, 2024 | 15.84B |
| March 12, 2024 | 16.00B |
| March 11, 2024 | 15.94B |
| March 08, 2024 | 16.14B |
| March 07, 2024 | 16.31B |
| March 06, 2024 | 15.96B |
| March 05, 2024 | 15.85B |
| March 04, 2024 | 15.73B |
| March 01, 2024 | 16.01B |
| February 29, 2024 | 15.49B |
| February 28, 2024 | 15.62B |
| February 27, 2024 | 15.42B |
| February 26, 2024 | 15.25B |
| February 23, 2024 | 15.15B |
| February 22, 2024 | 15.11B |
| February 21, 2024 | 14.81B |
| February 20, 2024 | 14.70B |
| February 16, 2024 | 15.01B |
| February 15, 2024 | 15.03B |
| February 14, 2024 | 15.02B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.545B
Minimum
Mar 18 2020
25.61B
Maximum
Sep 24 2021
13.95B
Average
13.45B
Median
Dec 09 2022
Enterprise Value Benchmarks
| Cardinal Health Inc | 25.38B |
| Stryker Corp | 138.15B |
| DaVita Inc | 21.28B |
| Inotiv Inc | 467.98M |
| Medpace Holdings Inc | 11.67B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 187.08M |
| Revenue (Quarterly) | 1.013B |
| Total Expenses (Quarterly) | 880.55M |
| EPS Diluted (Quarterly) | 3.64 |
| Gross Profit Margin (Quarterly) | 35.92% |
| Profit Margin (Quarterly) | 18.46% |
| Earnings Yield | 4.03% |
| Operating Earnings Yield | 5.24% |
| Normalized Earnings Yield | 4.030 |